Gary Sphar, CFO, Mylan Pharmaceuticals Inc at MYLAN LABORATORIES INC (MYL), sold 8,100 shares at $21.20 ($172K) on 2006-09-15, disclosed to the SEC on 2006-09-19.
Open-market sale of $172k MYL by CFO, Mylan Pharmaceuticals Inc. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.